Dose fractionation in neutron capture therapy for malignant melanoma.
Allen
B J
BJ
Australian Nuclear Science & Technology Organisation, Lucas Heights Research Laboratories, Menai, NSW.
Brown
J K
JK
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002453:Cell Cycle / Q000528:radiation effects; D002986:Clinical Trials as Topic; D006801:Humans; D008545:Melanoma / Q000532:radiotherapy*; D009502:Neutrons; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011878:Radiotherapy / Q000379:methods*
D000911:Antibodies, Monoclonal; C060302:4-bromophenylalanine; D010649:Phenylalanine